Urinary immunoglobulin G to albumin ratio and N-Acetyl-Beta-D-Glucosaminidase as early predictors of therapeutic response in ANCA-associated glomerulonephritis

PloS One
Marija MravljakJelka Lindic

Abstract

The aim of our study was to evaluate the prognostic value of glomerular and tubular proteinuria and tubular enzymuria as early indicators of therapeutic response to induction therapy with i.v. pulse cyclophosphamide (CyC) and methylprednisolone (MP) in patients with antineutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis. An observational single-center study was conducted in 30 patients with ANCA-associated glomerulonephritis. Patients were divided into subgroups with good or poor response to CyC therapy according to clinical and laboratory parameters. The diagnosis of ANCA-associated glomerulonephritis was based on the Chapel-Hill disease definitions. Good response to induction therapy was significantly associated with higher absolute values of urine N-acetyl-beta-D-glucosaminidase (NAG) to creatinine ratio (above 14.83 microcat/mol) and urine immunoglobulin G (IgG) to albumin ratio (above 0.09) at the time of diagnosis, while albuminuria or proteinuria did not have any early predictive value. The remission of renal disease was anticipated as early as 3 months after introduction of induction therapy in patients with reduction of urine NAG to creatinine ratio below the baseline value and in patients with at lea...Continue Reading

References

Jul 1, 1991·The Journal of Pathology·B J Addis
Feb 3, 1990·BMJ : British Medical Journal·E M DamsgaardC E Mogensen
Mar 1, 1983·Journal of Clinical Pathology·H YuI C MacLennan
Jan 15, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·L J ReichertJ F Wetzels
Apr 8, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M P BosomworthA W Hay
Oct 27, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·C J BurtonK P Harris
Jun 28, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·O BakoushJ Tencer
Aug 2, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C BazziG D'Amico
Sep 25, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·J C Jennette, D B Thomas
Jun 29, 2002·Journal of the American Society of Nephrology : JASN·Lavanya KameshCaroline O S Savage
Oct 10, 2002·Kidney International·Herbert A HauerUNKNOWN European Vasculitis Study Group (EUVAS)
Oct 29, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Claudio BazziGiuseppe D'Amico
Dec 25, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Penelope P KapitsinouHaralampos M Moutsopoulos
Mar 13, 2003·Kidney International·Giuseppe D'Amico, Claudio Bazzi
Apr 8, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sven WeidnerHarald D Rupprecht
Nov 4, 2004·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Priya J Bansal, Mary C Tobin
Nov 18, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Irmgard NeumannFranz Thomas Meisl
Jan 28, 2005·The New England Journal of Medicine·Paul A Bacon
Jan 28, 2005·The New England Journal of Medicine·UNKNOWN Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
Mar 9, 2005·Kidney International. Supplement·Norberto PericoGiuseppe Remuzzi
Jul 19, 2005·Journal of Clinical Laboratory Analysis·Dilek ErdenerFatma Z Kutay
Feb 2, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Omran BakoushJan Tencer
Apr 17, 2008·Annals of the Rheumatic Diseases·C MukhtyarUNKNOWN European Vasculitis Study Group
Dec 5, 2008·Annals of the Rheumatic Diseases·C MukhtyarR A Luqmani
May 20, 2009·Annals of Internal Medicine·Kirsten de GrootUNKNOWN EUVAS (European Vasculitis Study Group)
Apr 17, 2010·Journal of the American Society of Nephrology : JASN·Ronald J Falk, J Charles Jennette
Jul 10, 2010·Journal of the American Society of Nephrology : JASN·Annelies E BerdenIngeborg M Bajema
Dec 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Corrado TarellaAlessandro Rambaldi
Mar 19, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Nicholas MansfieldAlan D Salama
Jul 2, 2011·Journal of the American Society of Nephrology : JASN·Roland E SchmiederUNKNOWN ONTARGET Investigators
Jun 15, 2013·Journal of the American Society of Nephrology : JASN·Marc HilhorstUNKNOWN Limburg Renal Registry

❮ Previous
Next ❯

Citations

Jun 11, 2021·Analytical Biochemistry·Damian GarbiczWojciech Lisik

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.